Home1734 • TPE
add
Sinphar Pharmaceutical Co Ltd
Previous close
$32.45
Day range
$32.70 - $33.00
Year range
$27.25 - $36.30
Market cap
5.93B TWD
Avg Volume
344.78K
P/E ratio
19.51
Dividend yield
-
Primary exchange
TPE
Market news
Financials
Income Statement
Revenue
Net income
(TWD) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | 805.59M | 3.63% |
Operating expense | 234.15M | -4.49% |
Net income | 112.39M | 1.82% |
Net profit margin | 13.95 | -1.76% |
Earnings per share | 0.62 | — |
EBITDA | 176.36M | 32.14% |
Effective tax rate | 1.00% | — |
Balance Sheet
Total assets
Total liabilities
(TWD) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.12B | 9.37% |
Total assets | 6.32B | -0.43% |
Total liabilities | 2.64B | -6.25% |
Total equity | 3.67B | — |
Shares outstanding | 181.27M | — |
Price to book | 1.74 | — |
Return on assets | 4.41% | — |
Return on capital | 5.12% | — |
Cash Flow
Net change in cash
(TWD) | Mar 2025info | Y/Y change |
---|---|---|
Net income | 112.39M | 1.82% |
Cash from operations | 63.96M | 7.91% |
Cash from investing | -91.19M | 12.79% |
Cash from financing | -92.77M | -634.33% |
Net change in cash | -112.55M | -113.54% |
Free cash flow | 72.58M | 219.06% |
About
Founded
1977
Headquarters
Website
Employees
984